Integrating clinically actionable biomarkers into bladder cancer care — recommendations from the International Bladder Cancer Group

Nature Reviews Urology · Published 2026-08-05 · DOI 10.1038/s41585-026-01179-y

Free full text

Authors (31)

Patrick J. Hensley, Jeremy Y. C. Teoh, Roger Li, Shilpa Gupta, Laura Bukavina, Kent W. Mouw, Niyati Lobo, Brigida Anna Maiorano, Wei Shen Tan, Piyush Agarwal, Hikmat A. Al-Ahmadie, Trinity J. Bivalacqua, Liang Cheng, Thomas W. Flaig, Charles C. Guo, Amir Horowitz, Wassim Kassouf, Max R. Kates, Badrinath R. Konety, Janet B. Kukreja, Yair Lotan, David J. McConkey, Laura S. Mertens, Maria Carmen Mir, Marco Moschini, Andrea Necchi, Karima Oualla, Vignesh T. Packiam, Bogdana Schmidt, Roger J. Buckley, Ashish M. Kamat

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Hensley, P., Teoh, J., Li, R., et al. (2026). Integrating clinically actionable biomarkers into bladder cancer care — recommendations from the International Bladder Cancer Group. Nature Reviews Urology. https://doi.org/10.1038/s41585-026-01179-y

Related articles